ESG

A landmark $1.2M order for its advanced LineaDNA validates the firm's biotech arm, but can scientific success balance its new, volatile crypto strategy?

Formerly Cybin, Helus Pharma's Nasdaq launch marks a pivotal shift towards commercializing its breakthrough depression and anxiety drug pipeline.

A new 10,000-sample 'skin library' collected by painless stickers aims to slash drug development time and costs for biopharmaceutical partners.

Prenetics slashed future dilution risk by exchanging 4.7M warrants, a move analysts see as crucial for fueling the rapid growth of its IM8 wellness brand.

With a key drug decision looming and a refocused strategy, Rocket Pharmaceuticals faces a critical audience at the J.P. Morgan Healthcare Conference.

A new drug could redefine life for polycythemia vera patients, replacing frequent, burdensome blood draws with a simple weekly self-injection.

A humanoid robot named Nylo will manage IntBot's CES booth entirely alone, a high-stakes, unscripted test of AI's readiness for the real world.

The Ohio-based vertical farming giant is leveraging advanced tech and a strategic merger to bring its nutrient-dense microgreens to thousands of new stores.

In a major win, Rockwell Medical extends its DaVita supply deal through 2026 with a price hike, underscoring the value of its reliable supply chain.

Sanofi is investing up to $2.56 billion in Earendil Labs' AI platform to discover next-gen bispecific antibodies for complex autoimmune diseases.

A royal Saudi delegation's visit to tech giant TRANSSION in Shanghai signals a deep strategic partnership aimed at fueling Infinix's growth in the Kingdom.

Legence completes its acquisition of The Bowers Group, creating a dominant force in mission-critical building systems for the DC area and beyond.

CEO Eric Hambly will face investors at a key conference, balancing oil production strategy with the rising tide of clean technology and decarbonization.

Sony Honda Mobility's high-tech AFEELA 1 EV has started trial runs in Ohio, introducing a unique 'Quality Gate' to ensure its advanced tech is flawless.

Tesla's Q4 report shows a complex picture. Vehicle deliveries fell short, but record-breaking growth in the energy division hints at a major strategic shift.

FHLBank Chicago is injecting $55 million in subsidies to help local lenders in IL & WI fund affordable housing and small businesses.

A new device debuting at CES 2026 uses nerve stimulation to treat the entire menstrual experience, not just cramps. Is this the future of femtech?

Known for hair styling, Wavytalk is launching a clinically-tested LED mask. Can this at-home device truly rival professional skincare treatments?

JAS Worldwide promotes Manuele Mazzacurati to Chief Commercial Officer, signaling a strategy that prizes deep internal expertise to drive growth.

With a blockbuster 2025 in the books, Boston Scientific's leadership faces intense scrutiny at upcoming investor events to prove its growth is sustainable.